Results of a recent study indicate that regular consumption of mushrooms may decrease the risk of mild cognitive impairment.
Search Results: bough (16)
A recent study has demonstrated that overweight individuals may be more likely to survive a stroke than people of normal weight.
Alzheimer’s Research UK are funding a clinical trial to investigate the use of Sativex®, a cannabis-based medicine for the treatment of behavioral changes experienced as a result of dementia.
Researchers have identified natural killer cells as a potential therapeutic target for the treatment of neuropathic pain. The immune cells can selectively degenerate axons, allowing repair of damaged nerves.
A team of researchers have utilized radiocarbon dating to determine that there is little regeneration of oligodendrocytes in the brains of people living with multiple sclerosis. However, the oligodendrocytes that survive the autoimmune attack can replenish lost myelin.
Here we review your favorite and most-read pieces from all five of our partnered journals in 2018, giving you access to the most popular articles over the last year.
Three novel radiopharmaceuticals have been evaluated for their potential to be utilized in PET imaging of tau proteins in humans. The results of the study have the potential to improve the way we diagnose and treat Alzheimer’s disease.
A team of researchers have devised a novel method of diagnosing autism in children. Following analysis of short home videos of children, mathematical modelling was utilized to provide a numerical score indicating the severity of the developmental disorder.
A combination of CBL0137 and panobinostat has been demonstrated to effectively treat neuroblastoma in mice. This combination therapy has the potential to lead the fight against this aggressive childhood cancer.
SfN18: Can animal models offer an insight into human opioid addiction, withdrawal and relapse behaviors?
New studies in which animal models have been utilized to study opioid addiction, withdrawal and relapse may offer insights into managing the opioid epidemic in humans.